These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 20619340)

  • 1. Disruption of central nervous system barriers in multiple sclerosis.
    Alvarez JI; Cayrol R; Prat A
    Biochim Biophys Acta; 2011 Feb; 1812(2):252-64. PubMed ID: 20619340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune cell entry to central nervous system--current understanding and prospective therapeutic targets.
    Prendergast CT; Anderton SM
    Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):315-27. PubMed ID: 20028334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial influences on BBB functions and molecular players in immune cell trafficking.
    Lécuyer MA; Kebir H; Prat A
    Biochim Biophys Acta; 2016 Mar; 1862(3):472-82. PubMed ID: 26454208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
    Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
    Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
    Wang C; Wang C; Dong H; Wu XM; Wang C; Xia F; Li G; Jia X; He S; Jiang X; Li H; Xu H
    Mol Immunol; 2013 Jan; 53(1-2):43-51. PubMed ID: 22796503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions.
    Alvarez JI; Saint-Laurent O; Godschalk A; Terouz S; Briels C; Larouche S; Bourbonnière L; Larochelle C; Prat A
    Neurobiol Dis; 2015 Feb; 74():14-24. PubMed ID: 25448765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Junctional adhesion molecule-A deficient mice are protected from severe experimental autoimmune encephalomyelitis.
    Berve K; Michel J; Tietz S; Blatti C; Ivan D; Enzmann G; Lyck R; Deutsch U; Locatelli G; Engelhardt B
    Eur J Immunol; 2024 Jun; 54(6):e2350761. PubMed ID: 38566526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS.
    Li Z; Korhonen EA; Merlini A; Strauss J; Wihuri E; Nurmi H; Antila S; Paech J; Deutsch U; Engelhardt B; Chintharlapalli S; Koh GY; Flügel A; Alitalo K
    J Clin Invest; 2020 Apr; 130(4):1977-1990. PubMed ID: 32149735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The blood-central nervous system barriers actively control immune cell entry into the central nervous system.
    Engelhardt B
    Curr Pharm Des; 2008; 14(16):1555-65. PubMed ID: 18673197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Balasa R; Barcutean L; Balasa A; Motataianu A; Roman-Filip C; Manu D
    Hum Immunol; 2020 May; 81(5):237-243. PubMed ID: 32122685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier.
    Abadier M; Haghayegh Jahromi N; Cardoso Alves L; Boscacci R; Vestweber D; Barnum S; Deutsch U; Engelhardt B; Lyck R
    Eur J Immunol; 2015 Apr; 45(4):1043-58. PubMed ID: 25545837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis.
    Yang X; Yan J; Feng J
    Eur J Pharmacol; 2016 Jan; 771():18-28. PubMed ID: 26683637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do immune cells overcome the blood-brain barrier in multiple sclerosis?
    Larochelle C; Alvarez JI; Prat A
    FEBS Lett; 2011 Dec; 585(23):3770-80. PubMed ID: 21550344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TET inducible expression of the α4β7-integrin ligand MAdCAM-1 on the blood-brain barrier does not influence the immunopathogenesis of experimental autoimmune encephalomyelitis.
    Döring A; Pfeiffer F; Meier M; Dehouck B; Tauber S; Deutsch U; Engelhardt B
    Eur J Immunol; 2011 Mar; 41(3):813-21. PubMed ID: 21341265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of immune cell entry into the central nervous system.
    Engelhardt B
    Results Probl Cell Differ; 2006; 43():259-80. PubMed ID: 17068976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases.
    Aubé B; Lévesque SA; Paré A; Chamma É; Kébir H; Gorina R; Lécuyer MA; Alvarez JI; De Koninck Y; Engelhardt B; Prat A; Côté D; Lacroix S
    J Immunol; 2014 Sep; 193(5):2438-54. PubMed ID: 25049355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats.
    van der Laan LJ; van der Goes A; Wauben MH; Ruuls SR; Döpp EA; De Groot CJ; Kuijpers TW; Elices MJ; Dijkstra CD
    J Neurosci Res; 2002 Jan; 67(2):191-9. PubMed ID: 11782963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
    Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
    Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
    Jadidi-Niaragh F; Mirshafiey A
    Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.